Loading clinical trials...

COMPLETEDPhase 3NCT00656981

Evaluate Safety and Efficacy of an Oral Contraceptive (OC) Preparation Versus Placebo for 6 Treatment Cycles in Women With Moderate Acne

The objectives of this study were to evaluate the efficacy and safety of drospirenone 3 mg/ethinyl estradiol 0.02 mg (DRSP/EE) in comparison with placebo in female subjects with moderate acne vulgaris...

Lead sponsor: Bayer•22 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITING

Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris

NCT07205107 · Acne Vulgaris

RECRUITINGEARLY Phase 1

Weekly Isotretinoin vs Tetracycline for Moderate Acne

NCT06225570 · Acne Vulgaris

RECRUITINGPhase 1/2

Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy

NCT05891795 · Acne Vulgaris

RECRUITINGNA

Vitamin D Supplementation in Acne

NCT06141330 · Acne Vulgaris

RECRUITINGNA

Profiles Analysis of Genome Wide Association Study (GWAS) in Acne Vulgaris in Indonesia.

NCT06501560 · Acne Vulgaris

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 30, 2014Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment541

Start dateJan 2003

Last updatedDec 30, 2014

Condition

Acne Vulgaris

Locations shown

Mobile, Alabama

Kingman, Arizona

Encino, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 30, 2014Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions